Biological Evaluation of 2,3-Dioxoindolin-N-Phenylacetamide Derivatives As Potent CDC25B and PTP1B Phosphatase Inhibitors. Braz. J. Pharm. Sci. 2020, 56, e00222. https://doi.org/10.1590/s2175-97902019000400222.